New anticoagulant may prevent recurrent ischemic stroke
The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with asundexian reduced recurrent ischemic stroke and transient ischemic attack (TIA) without increasing ...
Aug 29, 2022
0
4